compounders sue fda over ending semaglutide shortage Drug declaration Wegovy Out of Shortage, Into Controversy:

Patients experiencing recurrent or persistent injection site reactions should discuss these concerns with their prescribing clinician, who may consider alternative formulations, dose adjustments, or switching to a different medication if symptoms significantly impact quality of life or treatment adherence

The Part D stages work like this: Deductible: you pay the full cost until you meet your plans deductible

Wegovy and Saxenda copy GLP-1, while Mounjaro copies both GLP-1 and GIP

Reproduction (2015) 150(4):28996

That contributes to higher drug costs

In contrast, health plans are more likely to evaluate obesity treatment through the lens of clinical effectiveness balanced with cost-efficiency, considering the large percentage of members who would be eligible to take the drugs